Search

everythinglearnresearchcommunity

for

Search:↓

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Morroniside has many health benefits, including protection against diabetes complications, bone and brain diseases, heart and skin issues, and it supports hair growth and reduces inflammation.

The (+) enantiomer of YH239-EE effectively kills breast cancer cells.

A postmenopausal woman's hirsutism and high testosterone levels improved after surgery for an ovarian tumor not seen on ultrasound.

Finasteride can cause sexual dysfunction and depression, which may persist and require hormonal treatment.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Iron levels are linked to insulin resistance in men and postmenopausal women, but not in premenopausal women.

The review suggests a comprehensive approach to treat hirsutism, focusing on hair removal, medication, and managing emotional effects.

Higher social status is linked to earlier diagnosis and better treatment results for Frontal Fibrosing Alopecia in women.

Cynomorium songaricum has many health benefits and could help with hair regrowth.

The document concludes that doctors should monitor children's brain development when treating hemangiomas with interferon alfa and consider stopping the treatment if problems arise, while also exploring drugs that might counteract side effects.

Sex hormones do not cause oral lichen planus.

Metformin helps reduce PCOS-related infertility by improving insulin sensitivity and inducing ovulation.

AGA is a common hair loss disorder, and early diagnosis and treatment with minoxidil or finasteride can help reduce emotional distress.

Collagen networks play a key role in hair loss and follicle miniaturization.

Ursolic acid from Ochrosia elliptica leaves may help manage PCOS symptoms.

A comprehensive, personalized approach is needed for treating female pattern hair loss and obesity, involving multiple medical disciplines and lifestyle changes.

Wedelolactone may help treat inflammation, infections, cancer, bone loss, and organ damage.

Oral lichen planus is not linked to sex hormone levels.

Exosomes from stem cells help hair regrowth by activating a specific signaling pathway.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.